
    NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellee, v. MYLAN PHARMACEUTICALS INC. and Mylan Inc., Defendants-Appellants.
    No. 2011-1203.
    United States Court of Appeals, Federal Circuit.
    Dec. 6, 2011.
    Larry L. Shatzer, Seth C. Silber, Wilson, Sonsini, Goodrich & Rosati, Washington, DC, Terrence J.P. Kearney, Ron E. Shulman, Richard G. Frenkel, Latham & Watkins LLP, Menlo Park, CA, Joshua Alan Chester Mack, Wilson, Sonsini, Goodrich & Rosati, San Diego, CA, for Defendants-Appellants.
    Nicholas N. Kallas, Diego Scambia, Christopher Earl Loh, Fitzpatrick, Celia, Harper & Scinto, New York, NY, for Plaintiff-Appellee.
   ON MOTION

ORDER

Mylan Pharmaceuticals Inc. and Mylan Inc. move to dismiss their appeal.

Upon consideration thereof,

It Is Ordered That:

(1) The motion is granted. The appeal is dismissed.

(2) Each side shall bear its own costs.  